世界中医药
文章摘要
引用本文:张媛媛1,李丽1,薛娟1,白彩云1,冯红礼2.米非司酮联合小金胶囊治疗子宫内膜异位症的临床研究[J].世界中医药,2017,(09):.  
米非司酮联合小金胶囊治疗子宫内膜异位症的临床研究
Clinical Research on Effects of Mifepristone Combined with Xiaojin Capsule in the Treatment of Endometriosis
投稿时间:2017-08-20  
DOI:10.3969/j.issn.1673-7202.2017.09.015
中文关键词:  子宫内膜异位症  小金胶囊  米非司酮
English Keywords:Endometriosis  Xiaojin capsule  Mifepristone
基金项目:2016年国家中医药管理局中药标准行动计划——小金胶囊标准化建设
作者单位
张媛媛1,李丽1,薛娟1,白彩云1,冯红礼2 1 延安大学附属医院妇产科延安716000 2 西安工程大学医院西安710048 
摘要点击次数: 1070
全文下载次数: 971
中文摘要:
      目的:观察米非司酮联合小金胶囊治疗子宫内膜异位症的临床疗效。方法:将本院120例符合子宫内膜异位症诊断标准的患者随机分为2组。对照组60例.给予米非司酮口服治疗。观察组60例,给予米非司酮联合小金胶囊口服。2组患者均连续治疗6个月后,观察2组治疗后的有效率、血清CA125、性激素水平、复发率及不良反应发生率等指标。结果:观察组临床总有效率均高于对照组(P<0.05),血清CA125、复发率低于对照组(P<0.05);2组性激素水平无明显差异(P>0.05)。结论:米非司酮联合小金胶囊对子宫内膜异位症有一定的疗效,值得临床推广。
English Summary:
      To observe the clinical effect of mifepristone combined with Xiaojin Capsule in the treatment of endometriosis.Methods:A total of 120 patients diagnosed as uterine fibroids were randomized divided into 2 groups.The control group (60 patients) were treated with Mifepristone, and the treatment group (60 patients) were added Xiaojin capsule.The effective rate, the levels of CA125, the levels of sex hormone, recurrence rate and adverse reaction of two groups after continuous 6 months' treatment were observed.Results:The total effective rate of treatment group was significantly higher than that of control group (P<0 05), and the levels of CA125 and recurrence rate were lower than that of control group.There was no significant difference in the levels of sex hormone (P>0.05).There were no significant difference in sex hormone levels of two groups (P>0.05).Conclusion:Mifepristone combined with Xiaojin capsule is effective for patients with endometriosis, which is worthy of clinical promotion.
查看全文  查看/发表评论  下载PDF阅读器